US Bone Scan Market Research Report: By Product (Radiopharmaceuticals, Imaging Devices) - Forecast to 2035

US Bone Scan Market Overview:

As per MRFR analysis, the US Bone Scan Market Size was estimated at 7.65 (USD Billion) in 2023. The US Bone Scan Market Industry is expected to grow from 8(USD Billion) in 2024 to 9.5 (USD Billion) by 2035. The US Bone Scan Market CAGR (growth rate) is expected to be around 1.575% during the forecast period (2025 - 2035).

Key US Bone Scan Market Trends Highlighted

The US Bone Scan Market is witnessing several key trends driven by advancements in medical imaging technology and a growing aging population. As the prevalence of osteoporosis and bone-related diseases increases among older adults, the demand for bone scans is significantly rising. Enhanced imaging techniques, such as single-photon emission computed tomography (SPECT) and positron emission tomography-computed tomography (PET-CT), are becoming more common, providing improved diagnostic capabilities and precision in detecting bone disorders. Alongside technological progress, the increasing awareness of preventative health measures among consumers has resulted in more patients seeking early diagnosis and treatment options, further expanding the market.There are numerous opportunities to be explored within the market. For instance, the integration of artificial intelligence and machine learning into imaging systems presents a chance to streamline processes, increase accuracy, and reduce operational costs. Additionally, collaborations between healthcare providers and technology companies can foster innovations, leading to enhanced patient outcomes. The establishment of imaging centers in underserved areas could also help cater to a larger demographic, ensuring that more patients have access to necessary diagnostic procedures. Recent trends in the US show a shift towards value-based care, emphasizing patient outcomes and satisfaction rather than volume of services provided.This shift encourages healthcare providers to adopt advanced imaging technologies, as accurate and timely diagnosis can lead to better treatment plans and reduced healthcare costs in the long run. Additionally, public health initiatives aimed at educating the population about bone health are becoming more prominent, which will likely increase demand for bone scans as part of comprehensive health assessments. Overall, the future of the US Bone Scan Market appears promising, fueled by innovation and a commitment to improving patient care.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

US Bone Scan Market Drivers

Increase in Bone-related Diseases

The rising incidence of bone-related diseases such as osteoporosis and arthritis is a significant driver for the US Bone Scan Market Industry. According to the National Osteoporosis Foundation, approximately 54 million Americans are affected by osteoporosis and low bone mass, with a particularly high prevalence in women aged 50 and older. This demographic is expected to continue growing due to the aging population, which the US Census Bureau projects will result in 83.7 million adults aged 65 and over by 2050.The increasing patient population requiring regular monitoring and diagnosis of bone-related ailments fuels demand for bone scans, emphasizing the critical role they play in preventive healthcare strategies.

Advancements in Imaging Technology

Technological advancements in imaging technology are propelling the growth of the US Bone Scan Market Industry. Enhanced imaging techniques, such as single-photon emission computed tomography (SPECT) and positron emission tomography (PET), provide higher quality images that can lead to more accurate diagnoses. The American College of Radiology highlights that new imaging technologies have reduced radiation exposure while increasing the resolution of bone scans, leading to improved patient outcomes.As these technologies become more accessible in healthcare facilities across the US, the frequency of bone scans is expected to rise, driven by their increasing efficacy in detecting abnormalities.

Rising Geriatric Population

The growing geriatric population in the United States is a significant factor contributing to the growth of the US Bone Scan Market Industry. According to the Administration for Community Living, the number of adults aged 65 and older is anticipated to reach approximately 95 million by 2060, which emphasizes a larger demographic susceptible to bone disorders. As older adults are more likely to suffer from diseases affecting bone density and integrity, regular bone scanning becomes increasingly essential for timely diagnosis and management of these conditions.Consequently, healthcare providers are focusing on incorporating bone scans into routine assessments for this age group.

Increased Awareness and Preventive Healthcare

Growing awareness of bone health and preventive healthcare practices is another driving factor for the US Bone Scan Market Industry. Campaigns led by health organizations, including the National Institute of Arthritis and Musculoskeletal and Skin Diseases, promote the importance of early detection and management of bone health issues. With increasing education surrounding osteoporosis and its consequences, more individuals are seeking bone scans as part of their routine health checkups.This trend, combined with growing efforts to promote preventive healthcare strategies, suggests a robust demand for bone scans, as patients and healthcare professionals recognize their importance in maintaining bone health.

US Bone Scan Market Segment Insights:

Bone Scan Market Product Insights

The US Bone Scan Market is an integral part of the broader healthcare landscape, primarily focused on the diagnosis and management of bone-related conditions such as osteoporosis, fractures, and metastatic diseases. This market is distinctly categorized into various products, with Radiopharmaceuticals and Imaging Devices emerging as significant segments. Radiopharmaceuticals play a crucial role in bone scans, as they are vital for effectively visualizing bone metabolism and pathology through nuclear imaging techniques. This segment addresses the increasing need for accurate diagnostic solutions and personalized treatment plans, particularly with the growing aging population in the US, which is prone to various bone diseases.In addition, Imaging Devices, which include advanced technologies such as single-photon emission computed tomography (SPECT) and positron emission tomography (PET), enhance the capabilities of bone scanning procedures. The rise in technological innovations within Imaging Devices is transforming traditional practices and provides superior imaging quality, allowing for early detection and better management of bone-related disorders. The combination of these advancements in Radiopharmaceuticals and Imaging Devices not only enhances diagnostic accuracy but also leads to improved patient outcomes, positioning these segments as central to the evolving landscape of the US Bone Scan Market.With the continuous evolution of imaging technologies and radiopharmaceutical applications, both segments are set to capitalize on emerging opportunities and address the growing demand for effective bone health management solutions across the US. This focus on both accuracy in diagnostics and advanced imaging methodologies highlights the critical importance of these segments in responding to the healthcare needs of the population.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

US Bone Scan Market Key Players and Competitive Insights:

The competitive landscape of the US Bone Scan Market is characterized by a dynamic array of companies that continually innovate and adapt to changing healthcare needs. This market focuses primarily on advanced imaging techniques utilized for evaluating bone health, diagnosing conditions such as osteoporosis, and detecting fractures. With increasing awareness regarding bone density health, a growing geriatric population, and rising incidences of bone-related disorders, the market exhibits substantial potential for growth. Companies in this sector are competing on multiple fronts including technological advancements, operational efficiencies, product differentiation, and strategic partnerships to enhance their presence and market share. The competitive insights reveal a landscape that emphasizes innovation, customer-centric approaches, and regulatory compliance as cornerstone strategies for success.Hologic has carved out a significant niche in the US Bone Scan Market thanks to its commitment to women's health and technological advancements in medical imaging. The company leverages its expertise in bone health assessment and employs state-of-the-art dual-energy x-ray absorptiometry (DXA) technology to provide precise and reliable evaluations of bone density. Hologic's strong brand reputation is bolstered by its extensive research and clinical validation, resulting in high-quality products that are widely accepted by healthcare providers. Furthermore, Hologic’s strong focus on education and support for healthcare professionals ensures that it remains a trusted partner in the market. The company’s strategic investments in innovation and its responsive approach to market demands enhance its competitive position within the bone scan sector.Baker Hughes, while primarily known for its oil and gas products, has made strategic investments in the healthcare sector, influencing the US Bone Scan Market with innovative solutions that leverage advanced imaging technologies. The company has diversified its service offerings to include equipment and support for bone health assessments, showcasing its commitment to addressing healthcare challenges. Baker Hughes employs a unique approach through the integration of its engineering expertise, thus creating high-quality imaging solutions that enhance diagnostic accuracy. The company's strong market presence is supported by its focus on collaborations and potential mergers that aim to expand its healthcare footprint. Moreover, Baker Hughes is committed to ongoing research and development, positioning itself favorably to leverage emerging technologies in the bone scan domain while maintaining a robust service network across the U.S.

Key Companies in the US Bone Scan Market Include:

Hologic

Baker Hughes

Aeronamic

Medtronic

United Imaging

Agfa HealthCare

PerkinElmer

CureMetrix

Elekta

Siemens Healthineers

Canon Medical Systems

Bracco Diagnostics

General Electric

Philips Healthcare

ADAC Laboratories

US Bone Scan Market Industry Developments

Recent developments in the US Bone Scan Market have highlighted a focus on advanced imaging technologies and machine learning applications. Companies such as Siemens Healthineers and Hologic have been at the forefront, introducing innovative bone density scanning equipment that combines precise imaging with efficiency. The market has seen a positive growth trajectory, with an increased emphasis on early diagnosis of bone-related disorders. In October 2023, Siemens Healthineers made strides in expanding their offerings by announcing collaborations aimed at enhancing imaging software solutions, which may significantly improve diagnosis accuracy for conditions such as osteoporosis. Moreover, growth in market valuation for major players like Medtronic and Phillips Healthcare has been reported, bolstered by rising healthcare expenditures and an aging population in the US. In terms of mergers and acquisitions, Hologic acquired a diagnostic imaging company in September 2023 to bolster its portfolio, creating a ripple effect in competitive strategies within the market. The ongoing integration of Artificial Intelligence solutions into bone imaging is accelerating as well, with companies like CureMetrix making advancements that further optimize bone scan results, underscoring the dynamic landscape of the US Bone Scan Market.

US Bone Scan Market Segmentation Insights

Bone Scan Market Product Outlook

Radiopharmaceuticals

Imaging Devices

Report Scope:

Report Attribute/Metric Source:	Details
MARKET SIZE 2018	7.65(USD Billion)
MARKET SIZE 2024	8.0(USD Billion)
MARKET SIZE 2035	9.5(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	1.575% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	Hologic, Baker Hughes, Aeronamic, Medtronic, United Imaging, Agfa HealthCare, PerkinElmer, CureMetrix, Elekta, Siemens Healthineers, Canon Medical Systems, Bracco Diagnostics, General Electric, Philips Healthcare, ADAC Laboratories
SEGMENTS COVERED	Product
KEY MARKET OPPORTUNITIES	Aging population growth, Increased osteoporosis prevalence, Advancements in imaging technology, Rising demand for early diagnosis, Expanding outpatient imaging centers
KEY MARKET DYNAMICS	increasing prevalence of osteoporosis, advancements in imaging technology, rising geriatric population, increasing demand for early diagnosis, growing awareness of bone health
COUNTRIES COVERED	US